The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic
4.8 (425) · $ 13.00 · In stock
PGHN :: Pediatric Gastroenterology, Hepatology & Nutrition
Metabolites, Free Full-Text
PDF] A Protein‐Truncating HSD17B13 Variant and Protection from Chronic Liver Disease
Promoting genetics in non-alcoholic fatty liver disease: Combined risk score through polymorphisms and clinical variables
Hepatocellular carcinoma in nonalcoholic fatty liver disease: A growing challenge
Evolution of Non-alcoholic Fatty Liver Disease to Liver Cancer: Insights from Genome-wide Association Studies
Non-alcoholic fatty liver disease-related hepatocellular carcinoma
Lack of evidence supporting a role of TMC4-rs641738 missense variant—MBOAT7- intergenic downstream variant—in the Susceptibility to Nonalcoholic Fatty Liver Disease
Genetic and metabolic aspects of non-alcoholic fatty liver disease (NAFLD) pathogenicity, Egyptian Journal of Medical Human Genetics
MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C
Hepatocyte nuclear factor 4α in the pathogenesis of non-alcoholic fatty liver disease
New insights into genetic predisposition and novel therapeutic targets for nonalcoholic fatty liver disease - Barbara - Hepatobiliary Surgery and Nutrition
Distinct contributions of metabolic dysfunction and genetic risk factors in the pathogenesis of non-alcoholic fatty liver disease. - Abstract - Europe PMC
Hepatocyte nuclear factor 4α in the pathogenesis of non-alcoholic fatty liver disease
Precision medicine in nonalcoholic fatty liver disease: New therapeutic insights from genetics and systems biology
